Clinical trial
Zoledronic Acid to Prevent Bone Loss After Acute Spinal Cord Injury
NCT01642901 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zoledronic Acid to Prevent Bone Loss After Acute Spinal Cord Injury
- Lead sponsor
- Thomas Jefferson University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- March 31, 2018
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spinal cord injury